Back to Journals » Nutrition and Dietary Supplements » Volume 6

The antioxidant advantage of the Mediterranean diet in cardiovascular disease

Authors El-Sabban F 

Received 28 December 2013

Accepted for publication 6 March 2014

Published 19 May 2014 Volume 2014:6 Pages 35—40

DOI https://doi.org/10.2147/NDS.S59848

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Download Article [PDF] 

Farouk El-Sabban

Department of Food Science and Nutrition, College of Life Sciences, Kuwait University, Kuwait City, Kuwait


Abstract: To date, discrepancy exists among scientific data in regard to the benefit of administering antioxidant vitamin supplementation to cardiovascular disease (CVD) patients or toward protecting those who are at risk. Data of conducted randomized-controlled clinical trials so far did not produce solid evidence for the benefit of supplementing such antioxidant vitamins. Several meta-analyses confirmed that there was no effect of such supplementation, and adverse effects resulted when vitamin E was given in high doses. Thus, there is no scientific or medical basis to recommend the use of antioxidant vitamin supplements for CVD risk reduction at present. Currently, recommendations focus more on the naturally-occurring vitamins and other phytochemical antioxidants found in common dietary items. With emphasis being directed to the adequacy of the diet to provide needed antioxidants, this article explores the aspect of adequacy of the Mediterranean-type diet and dietary habits of inhabitants of this region. Collectively, the Mediterranean diet consists of food items that contain a number of antioxidants, and thus is likely to be adequate in providing a dietary level of antioxidants. Such dietary patterns should be preserved and promoted for the derived benefits to reduce the risk of CVD in the long run.

Keywords: antioxidants, health, lifestyle, nutrition, phytochemicals, vitamins

Introduction

Cardiovascular diseases (CVDs) are leading causes of death in many developed and developing countries, including the Middle East Region.1,2 Several studies revealed a role of low-density lipoprotein oxidation in the development of atherosclerosis. This has led to the thought that antioxidants can be helpful in protecting against and treating a number of CVDs.3 Dietary recommendations to reduce the risk of CVD have been directed toward reducing intake of saturated fat, trans fat, and cholesterol as well as to increase dietary fiber consumption. Such recommendations have promoted a dietary pattern that focuses on the consumption of diets rich in fruits, vegetables, whole grains, low-fat or nonfat dairy products, fish, legumes, poultry, and lean meats.4 Many epidemiological and population studies reported that antioxidant vitamins such as vitamin E, vitamin C, and beta-carotene may be beneficial to reduce the risk for CVD.5 Currently, there is an interest in assessing the value of many plant-based phytochemicals, such as carotenoids, catechins, and flavonoids, that exert an antioxidant effect to reduce the risk of CVD. A number of clinical studies reported the effects of antioxidant vitamin and mineral supplements on CVD risk.3,611 Data on the use of antioxidant supplements to reduce the risk of CVD showed inconsistent results. Thus, the question of whether or not supplemental antioxidant vitamins are effective still remains. Lack of solid evidence of beneficial effects of supplementation of antioxidant vitamins to reduce the risk of CVD would logically lead to reliance on naturally-occurring antioxidants of dietary sources. The purpose of this article is to provide a present-day stand on the issue of supplementing antioxidants in CVD and to explore the antioxidant compounds contained in the Mediterranean-type diet that form the basis of benefits to reduce the risk of CVD.

Results of clinical trials

Few clinical trials on antioxidant vitamin supplementation have been conducted. Data of these studies involved supplementation with vitamin E, beta-carotene, or vitamin C, either separately or in selected combinations of two or all three. The duration of these trials varied and involved patients with many CVDs and conditions. Outcomes under study included myocardial infarction, fatal and non-fatal coronary disease, changes in thickness of the intima-media of arterial wall, overall mortality due to ischemic heart disease, hemorrhagic and ischemic stroke, and all-cause mortality. Table 1 shows that obtained results of conducted trials were varied; some studies showed beneficial effects,1216 others did not prove to be beneficial,1725 while others yielded adverse effects.2628

Table 1 Summary of clinical trials showing beneficial, nonbeneficial, and adverse effects of antioxidant vitamin supplementation to female and male patients
Abbreviations: CVD, cardiovascular disease; F, female(s); M, male(s); MI, myocardial infarction.

Critical appraisal and consensus

Recent articles and meta-analyses provided confirmation that antioxidant vitamin supplementation proved noneffective in CVD.2931 A meta-analysis of 15 studies (seven studies of vitamin E, 50–800 IU; eight studies of beta-carotene, 15–50 mg) with 1,000 or more subjects per trial has been conducted to ascertain the effects of antioxidant vitamins on cardiovascular morbidity and mortality.32 This meta-analysis revealed the lack of efficacy for the different doses of the administered antioxidants in varied population groups. A computerized search and analysis of relevant studies on treatment with vitamin E showed no statistically significant or clinical importance to such supplementation.33 Thus, it seems that clinical trials have failed to demonstrate a beneficial effect of antioxidant supplements on CVD morbidity and mortality. Another meta-analysis revealed that high doses of vitamin E supplementation (greater than 150 IU/day) may progressively increase all-cause mortality.34 Conclusions of this analysis created a stir among specialists in the field.35 Thus, it seems likely that the debate over this subject will continue until concrete scientific evidence is found.

Many factors may have contributed to the lack of benefits of such supplementation so far. Conducted clinical studies (trials) differed in many respects with regard to subject populations studied (including those who are healthy), type and dose of antioxidant, single vitamin supplementation or cocktail, length of study, and study outcomes. Additionally, only known antioxidant vitamins were used, and their synthetic forms were used in some of the trials while their natural forms were used in others.36 Also, subjects of these trials were followed-up for varied durations ranging from 1–12 years. Therefore, these factors make it difficult to fully assess the real value of supplementing antioxidants to reduce the risk of CVD. However, while these particular trials failed to provide evidence of beneficial effects, this would not nullify the role of oxidative mechanisms in the development of atherosclerosis.36 More in vitro and in vivo investigations as well as sound experimentally controlled studies are needed. Future clinical trials ought to be conducted with a few but known variables to secure more reliable data. As antioxidant compounds differ quantitatively and qualitatively from one another, they should not be used in combination. For the purpose of medical practice, it is clear that existing data do not support prescribing the routine use of antioxidant supplements for the prevention and treatment of CVD.9,10,32,37,38 Thus, there is presently no scientific or medical basis to recommend individuals to take antioxidant vitamin supplements to reduce their risk of CVD.

Meanwhile, scientific evidence supports recommending consumption of a diet that is high in sources of antioxidants and other cardioprotective nutrients such as fruits, vegetables, whole grains, and nuts instead of antioxidant supplements to reduce the risk for CVD.39,40 Results of a meta-analysis suggested that increase in dietary intake of antioxidant vitamins has encouraging prospects for possible coronary heart disease prevention.41 In support of this view, it has been recently expressed that it may be misleading to focus on a single element of the diet, as if searching for a “magic bullet” for preventing a myriad of chronic diseases.42 Current recommendations included the intake of natural food sources of antioxidant nutrients, principally from a variety of plant-derived foods such as fruits, vegetables, whole grain products, and vegetable oils.43 These recommendations were also among several that emphasized an active and healthy lifestyle for an overall health benefit. With this being the prevailing view, future clinical trials should also consider the dietary antioxidant content in the overall scope of their design.

Antioxidants and the Mediterranean diet

With the lack of a solid recommendation for supplementing antioxidant vitamins to those who suffer from CVD or are at high risk for it, as well as to healthy individuals, emphasis is presently directed toward following a healthy diet and securing needed antioxidants from their natural sources.44 Vitamins known for their antioxidant property are found in commonly consumed food items such as vitamin A, found in liver, dairy products, and fish; vitamin C, found in green peppers and citrus fruits; vitamin E, found in oils, sunflower seeds, and nuts. Selenium, a trace mineral that is believed to help in protecting cells from free radical damage, is found in Brazil nuts, meats, and tuna. Antioxidants are not just limited to known vitamins but also include a number of compounds that are capable of protecting against oxidative damage. Some of these compounds, known as phytochemicals, are currently being recognized, and it seems others are still to be discovered. Among the known phytochemicals are sulfur allyls, cysteine, and allicin (found in garlic, onions, chives, leeks, and scallions); sulforane, brassin, indoles, glucosinolates, isothiocyanate (found in broccoli, kale, brussel sprouts, cabbage, and cauliflower); terpenes and flavones (found in citrus fruits); flavonoids, ellagic, and quercetin (found in grapes, wine, and cranberries); flavonoids, polyphenols, and catechins (found in green and black teas); oleuropein and hydroxytyrosol (found in extra virgin olive oil); and lycopene (found in tomatoes and watermelon).4547 Epidemiological studies have shown that diets rich in fruits, herbs, and spices are associated with a low risk for CVD.48 Garlic, for example, contains a number of compounds, among which are antioxidants that can be beneficial to reduce the risk of atherosclerosis and with antiplatelet aggregation action.4951 Dual-derived benefits of olive oil consumption include its content of a number of antioxidants and of monounsaturated fatty acids.52 Virgin olive oil is also rich in micronutrients,53 and regular consumption of olive oil has been found to be conducive to longevity.54 Individuals who commonly consume a diet that is high in monounsaturated fatty acids and high intake of garlic, onions, fresh fruits, and vegetables can benefit from the phytochemicals contained in such food items.55 Realizing the beneficial roles of antioxidants in scavenging free radical has recently led to the idea of establishing a database for their contents in food items.56

The Mediterranean diet is a modern nutritional recommendation based on the traditional dietary patterns of Greece, Spain, and Southern Italy. It is characterized by proportionally high consumption of olive oil, legumes, unrefined cereals, fruits, and vegetables, with moderate to high consumption of fish. It also includes moderate consumption of dairy products (mostly cheese and yogurt), wine, and low consumption of meat and meat products.57 The Mediterranean diet has been recognized by the United Nations Educational, Scientific and Cultural Organization (UNESCO) as being an intangible cultural heritage of many of the Mediterranean Sea basin countries, namely Spain, Portugal, Morocco, Italy, Greece, Cyprus, and Croatia in December 2013.57,58 However, the diet is being followed by many people worldwide as a part of a healthy lifestyle.

The protective effects of antioxidants to reduce the risk of major diseases such as cancer and CVD have been the focus of many studies. As for breast cancer, oxidative stress was associated with its incidence, and antioxidants can combat such adverse effect.59,60 Dietary antioxidants were found effective to reduce the risk of breast cancer.6164 Antioxidants of the Mediterranean diet were described as the choice for cancer prevention in Europe.65 Benefits of the Mediterranean-type diet were reported in a study that compared many of the risks of CVD and mortality between railroad workers in the US and Italy, for 25 years. Dietary patterns in Italy were implicated in reduced risks for CVD and mortality.66 Ever since then, the Mediterranean diet has been viewed as the most consistently beneficial measure with respect to risks of CVD6769 and as a model to provide protection against coronary heart disease.70 An energy-unrestricted Mediterranean diet that was supplemented with extra virgin olive oil was efficient in the primary prevention of CVD.71 Thus, this dietary pattern has been characterized as being cardioprotective.55

Concluding remarks

Collective data of all types of studies are inconsistent and do not provide solid evidence to recommend supplementation with one or more antioxidant vitamin as being beneficial in protection against CVD or reducing its risk factors. Until more clinical trials are conducted and become sufficient in number for evidence-based analysis to indicate a solid benefit for supplementation with antioxidants, the current view is not to administer supplements in medical practice. This means that emphasis would be directed toward aspects of healthy diet and lifestyle. With our current scientific knowledge about antioxidants and their food sources, increased consumption of such food items would make a practical recommendation for improving health. While well-controlled scientific research continues to elucidate mechanisms of action for particular antioxidant compounds, individually or in combinations, it is also important and practical to view dietary habits and patterns as a “whole package” and assess their real combined value. As far as food-based antioxidants are concerned, the Mediterranean dietary patterns can be viewed as mostly adequate. However, future studies on dietary antioxidants can utilize the new concept of “total antioxidant capacity”7274 for attaining reliable and quantifiable data for consumed food items. This approach would prove valuable nutritionally and in relation to aspects of public health. Based on what has been explored herein, the Mediterranean diet has many food items that furnish adequate amounts of a variety of antioxidants, whether known vitamins or phytochemicals. A multicountry effort has been launched toward devising a Mediterranean diet pyramid and in promoting this diet type.75 In this context, it should be mentioned that the wide spread of fast food restaurants all over the world and the menus they offer can be viewed as a danger to the prevalent Mediterranean-type dietary pattern, as they are high in calories and fat and do not provide significant plant-derived antioxidants. Thus, it is of significance to inhabitants of the Mediterranean Sea basin countries in the Middle East as well as those who follow their diet worldwide to preserve this dietary pattern. In this respect, this diet type should also be promoted for best benefits to reduce the risk of CVD and for an overall healthy existence.

Disclosure

The author reports no conflicts of interest in this work.


References

1.

Alwan AA. Cardiovascular diseases in the eastern Mediterranean region. World Health Stat Q. 1993;6(2):97–100.

2.

Rimm EB, Stampfer MJ. Diet, lifestyle, and longevity – the next steps? JAMA. 2004;292(12):1490–1492.

3.

Willcox BJ, Curb JD, Rodriguez BL. Antioxidants in cardiovascular health and disease: key lessons from epidemiological studies. Am J Cardiol. 2008;101(10A):75D–86D.

4.

Krauss RM, Eckel RH, Howard B, et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 2000;102(18):2284–2299.

5.

Osganian SK, Stampfer MJ, Rimm E, et al. Vitamin C and risk of coronary heart disease in women. J Am Coll Cardiol. 2003;42(2):246–252.

6.

Kritharides L, Stocker R. The use of antioxidant supplements in coronary heart disease. Atherosclerosis. 2002;164(2):211–219.

7.

Salonen JT. Clinical trials testing cardiovascular benefits of antioxidant supplementation. Free Radic Res. 2002;36(12):1299–1306.

8.

Morris CD, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the US. Preventive Services Task Force. Ann Intern Med. 2003;139(1):56–70.

9.

Heinecke JW. Clinical trials of vitamin E in coronary artery disease: is it time to reconsider the low-density lipoprotein oxidation hypothesis? Curr Atheroscler Rep. 2003;5(2):83–87.

10.

Gotto AM. Antioxidants, statins, and atherosclerosis. J Am Coll Cardiol. 2003;41(7):1205–1210.

11.

Kris-Etherton PM, Lichtenstein AH, Howard BV, Steinberg D, Witztum JL; Nutrition Committee of the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Antioxidant vitamin supplements and cardiovascular disease. Circulation. 2004;110(5):637–641.

12.

Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347(9004):781–786.

13.

Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 1997;349(9067):1715–1720.

14.

Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000;356(9237):1213–1218.

15.

Salonen JT, Nyyssönen K, Salonen R, et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med. 2000;248(5):377–386.

16.

Fang JC, Kinlay S, Beltrame J, et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet. 2002;359(9312):1108–1113.

17.

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet. 1999;354(9177):447–455.

18.

de Gaetano G; Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet. 2001;357(9250):89–95.

19.

Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):154–160.

20.

Lonn E, Yusuf S, Hoogwerf B, et al; HOPE Study; MICRO-HOPE Study. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care. 2002;25(11):1919–1927.

21.

Hodis HN, Mack WJ, LaBree L, et al; VEAPS Research Group. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation. 2002;106(12):1453–1459.

22.

Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334(18):1145–1149.

23.

Greenberg ER, Baron JA, Karagas MR, et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA. 1996;275(9):699–703.

24.

Virtamo J, Rapola JM, Ripatti S, et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med. 1998;158(6):668–675.

25.

Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):23–33.

26.

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330(15):1029–1035.

27.

Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345(22):1583–1592.

28.

Waters DD, Alderman EL, Hsia J, et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA. 2002;288(19):2432–2440.

29.

Pashkow FJ. Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention? Int J Inflam. 2011;2011:514623.

30.

Bjelakovic G, Nikolova D, Gludd LL, Simonetti RG, Gludd C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases [webpage on the Internet]. Cochrane Summaries; 2012. Available from: http://summaries.cochrane.org/CD007176. Accessed April 15, 2014.

31.

Myung SK, Ju W, Cho B, et al; Korean Meta-Analysis Study Group. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;346:f10.

32.

Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361(9374):2017–2023.

33.

Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol. 2008;101(10A):14D–19D.

34.

Miller ER 3rd, Pastor-Burriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage of vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37–46.

35.

Letters – comments and responses: high-dosage vitamin E supplementation and all-cause mortality. Ann Intern Med. 2005;143(2):150–158.

36.

Eidelman RS, Hollar D, Herbert PR, Lamas GA, Hennekens CH. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med. 2004;164(14):1552–1556.

37.

Brown BG, Cheung MC, Lee AC, Zhao XQ, Chait A. Antioxidant vitamins and lipid therapy: end of a long romance? Arterioscler Thromb Vasc Biol. 2002;22(10):1535–1546.

38.

Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation. 2002;105(17):2107–2111.

39.

Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996;334(18):1156–1162.

40.

Ye Z, Song H. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil. 2008;15(1):26–34.

41.

Hu FB. Plant-based foods and prevention of cardiovascular disease: an overview. Am J Clin Nutr. 2003;78(Suppl 3):544S–551S.

42.

Giugliano D, Esposito K. Mediterranean diet and cardiovascular disease. Ann NY Acad Sci. 2005;1056:253–260.

43.

Lichtenstein AH, Appel LJ, Brands M, et al; American Heart Association Nutrition Committee. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114(1):82–96.

44.

Kumar SV, Saritha G, Fareedullah MD. Role of antioxidants and oxidative stress in cardiovascular diseases. Ann Biol Res. 2010;1(3):158–173.

45.

http://www.phytochemicals.info/plants/olive.php, phytochemicals table 2. Accessed April 15, 2014.

46.

Functional foods fact sheet: antioxidants. International Food Information Council. March 2006. http://www.runvie.com/Articles/Antioxidants%20IFICF-org%202009.pdf. Accessed April 16, 2014.

47.

Al-Lafi AR, Al-Mutawaa A, Al-Awadi AA, Al-Rashed B. In vitro bioaccessibility assessment of lycopene in raw tomato and Kuwaiti tomato sauce (daqous). J Gulf Arab Penin Stud. 2013;39(151):17–28.

48.

Rajaram S. The effect of vegetarian diet, plant foods, and phytochemicals on hemostasis and thrombosis. Am J Clin Nutr. 2003;78(Suppl 3):552S–558S.

49.

El-Sabban F, Abouazra H. Effect of garlic on atherosclerosis and its factors. East Mediterr Health J. 2008;14(1):195–205.

50.

El-Sabban F, Radwan GM. Influence of garlic compared to aspirin on induced photothrombosis in mouse pial microvessels, in vivo. Thromb Res. 1997;88(2):193–203.

51.

Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: a review. Nutr J. 2002;1:4.

52.

Battino M, Ferreiro MS. Ageing and the Mediterranean diet: a review of the role of dietary fats. Public Health Nutr. 2004;7(7):953–958.

53.

Pérez-Jiménez F, Ruano J, Perez-Martinez P, Lopez-Segura F, Lopez-Miranda J. The influence of olive oil on human health: not a question of fat alone. Mol Nutr Food Res. 2007;51(10):1199–1208.

54.

Trichopoulou A, Dilis V. Olive oil and longevity. Mol Nutr Food Res. 2007;51(10):1275–1278.

55.

Mackenbach JP. The Mediterranean diet story illustrates that “why” questions are as important as “how” questions in disease explanation. J Clin Epidemiol. 2007;60(2):105–109.

56.

Haytowitz DB, Bhagwat S. USDA database for the oxygen radical capacity (ORAC) of selected foods, release 2 [webpage on the internet]. Washington, DC: US Department of Agriculture; 2010. Available from: http://www.ars.usda.gov/pandp/people/people.htm?personid=32873. Accessed October 28, 2013.

57.

Mediterranean diet: a heart-healthy eating plan. Mayo Clinic. http://www.mayoclinic.org/healthy-living/nutrition-and-healthy-eating/in-depth/mediterranean-diet/art-20047801. Accessed April 15, 2014.

58.

Mediterranean diet. United Nations Educational, Scientific and Cultural Organization. http://www.unesco.org/new/en/media-services/multimedia/photos/intangible-photo-gallery-2013/mediterranean-diet/. Accessed April 15, 2014

59.

Kang DH. Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues. 2002;13(4):540–549.

60.

Ambrosone CB. Oxidants and antioxidants in breast cancer. Antioxid Redox Signal. 2000;2(4):903–917.

61.

Michels KB, Holmberg L, Bergkvist L, Ljung H, Bruce A, Wolk A. Dietary antioxidant vitamins, retinol, and breast cancer incidence in a cohort of Swedish women. Int J Cancer. 2001;91(4):563–567.

62.

Ching S, Ingram D, Hahnel R, Beilby J, Rossi E. Serum levels of micronutrients, antioxidants and total antioxidant status predict risk of breast cancer in a case control study. J Nutr. 2002;132(2):303–306.

63.

Sharhar S, Normah H, Fatimah A, et al. Antioxidant intake and status, and oxidative stress in relation to breast cancer risk: a case-control study. Asian Pac J Cancer Prev. 2008;9(2):343–349.

64.

Aune D, Chan DS, Vieira AR, et al. Dietary compared with blood concentrations of carotenoids and breast cancer risk: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2012;96(2):356–373.

65.

Giacosa A, Barale R, Bavaresco L, et al. Cancer prevention in Europe: the Mediterranean diet as a protective choice. Eur J Cancer Prev. 2013;22(1):90–95.

66.

Menotti A, Seccareccia F, Blackburn H, Keys A. Coronary mortality and its prediction in samples of US and Italian railroad employees in 25 years within the Seven Countries Study of cardiovascular diseases. Int J Epidemiol. 1995;24(3):515–521.

67.

de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99(6):779–785.

68.

Serra-Majem L, Roman B, Estruch R. Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev. 2006;64(2 Pt 2):S27–S47.

69.

Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr. 2010;92(5):1189–1196.

70.

Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169(7):659–669.

71.

Estruch R, Ros E, Salas-Salvadó J, et al; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279–1290.

72.

Pellegrini N, Serafini M, Colombi B, et al. Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nutr. 2003;133(9):2812–2819.

73.

Wu X, Gu L, Holden J, et al. Development of a database for total antioxidant capacity in foods: a preliminary study. J Food Comps Anal. 2004;17(3–4):407–422.

74.

Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HH, Martínez JA. Dietary total antioxidant capacity: a novel indicator of diet quality in healthy young adults. J Am Coll Nutr. 2009;28(6):648–656.

75.

Bach-Faig A, Berry EM, Lairon D, et al; Mediterranean Diet Foundation Expert Group. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011;14(12A):2274–2284.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]